Glycoproteins of Predicted Amphibian and Reptile Lyssaviruses Can Mediate Infection of Mammalian and Reptile Cells.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 08 2021
Historique:
received: 30 07 2021
revised: 24 08 2021
accepted: 27 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 12 2 2022
Statut: epublish

Résumé

Lyssaviruses are neurotropic rhabdoviruses thought to be restricted to mammalian hosts, and to originate from bats. The identification of lyssavirus sequences from amphibians and reptiles by metatranscriptomics thus comes as a surprise and challenges the mammalian origin of lyssaviruses. The novel sequences of the proposed American tree frog lyssavirus (ATFLV) and anole lizard lyssavirus (ALLV) reveal substantial phylogenetic distances from each other and from bat lyssaviruses, with ATFLV being the most distant. As virus isolation has not been successful yet, we have here studied the functionality of the authentic ATFLV- and ALLV-encoded glycoproteins in the context of rabies virus pseudotype particles. Cryogenic electron microscopy uncovered the incorporation of the plasmid-encoded G proteins in viral envelopes. Infection experiments revealed the infectivity of ATFLV and ALLV G-coated RABV pp for a broad spectrum of cell lines from humans, bats, and reptiles, demonstrating membrane fusion activities. As presumed, ATFLV and ALLV G RABV pp escaped neutralization by human rabies immune sera. The present findings support the existence of contagious lyssaviruses in poikilothermic animals, and reveal a broad cell tropism in vitro, similar to that of the rabies virus.

Identifiants

pubmed: 34578307
pii: v13091726
doi: 10.3390/v13091726
pmc: PMC8473393
pii:
doi:

Substances chimiques

Glycoproteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Viruses. 2021 Jan 06;13(1):
pubmed: 33419096
Emerg Infect Dis. 2009 Feb;15(2):280-4
pubmed: 19193273
J Virol. 1993 Apr;67(4):1811-6
pubmed: 8383211
Cell Host Microbe. 2020 Mar 11;27(3):441-453.e7
pubmed: 32004500
Eur J Cell Biol. 2012 Jan;91(1):10-6
pubmed: 21397981
J Neurovirol. 2005 Feb;11(1):82-7
pubmed: 15804965
Emerg Infect Dis. 2013 May;19(5):793-5
pubmed: 23648051
J Biol Chem. 2002 Oct 4;277(40):37655-62
pubmed: 12163480
Nat Methods. 2007 Jan;4(1):47-9
pubmed: 17179932
Science. 1982 Jan 8;215(4529):182-4
pubmed: 7053569
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7306-11
pubmed: 23589850
PLoS Pathog. 2018 Jul 20;14(7):e1007189
pubmed: 30028877
Emerg Infect Dis. 2003 Dec;9(12):1623-5
pubmed: 14720408
J Virol. 2001 Apr;75(7):3268-76
pubmed: 11238853
Brain Struct Funct. 2015;220(3):1369-79
pubmed: 24723034
Virus Res. 2010 May;149(2):197-210
pubmed: 20138934
J Virol. 1995 Mar;69(3):1444-51
pubmed: 7853476
Virus Genes. 2021 Feb;57(1):40-49
pubmed: 33159637
Viruses. 2014 Aug 04;6(8):2974-90
pubmed: 25093425
J Neurovirol. 2011 Aug;17(4):353-67
pubmed: 21805057
Viruses. 2012 Jan;4(1):117-39
pubmed: 22355455
J Gen Virol. 2005 Sep;86(Pt 9):2543-2552
pubmed: 16099913
J Virol. 1991 Sep;65(9):4853-9
pubmed: 1870204
J Med Virol. 2020 Apr;92(4):433-440
pubmed: 31967321
J Virol. 1999 Jan;73(1):242-50
pubmed: 9847327
Nature. 2018 Apr;556(7700):197-202
pubmed: 29618816
J Virol. 1999 Jan;73(1):251-9
pubmed: 9847328
PLoS Pathog. 2021 Apr 21;17(4):e1009064
pubmed: 33882114
F1000Res. 2017 Feb 23;6:184
pubmed: 28299201
Virus Res. 2016 May 2;216:41-54
pubmed: 26065596
Acta Virol. 1990 Apr;34(2):155-63
pubmed: 1975976
J Gen Virol. 2001 Dec;82(Pt 12):2861-2867
pubmed: 11714960
Emerg Infect Dis. 2012 Apr;18(4):664-7
pubmed: 22469151
J Gen Virol. 2003 Jun;84(Pt 6):1613-1621
pubmed: 12771432
Virology. 1992 Apr;187(2):627-32
pubmed: 1546457
Science. 2010 Aug 6;329(5992):676-9
pubmed: 20689015
J Interferon Cytokine Res. 2009 Sep;29(9):499-509
pubmed: 19715459
PLoS One. 2011;6(11):e28131
pubmed: 22140523
Cell Host Microbe. 2017 Sep 13;22(3):387-399.e6
pubmed: 28867387
PLoS Pathog. 2020 Mar 9;16(3):e1008383
pubmed: 32150590
J Virol. 2007 Dec;81(24):13622-30
pubmed: 17928338
Cell Rep. 2020 Aug 18;32(7):108042
pubmed: 32814045
Front Neural Circuits. 2009 Dec 11;3:21
pubmed: 20126518
J Virol. 2015 Dec 09;90(4):2031-8
pubmed: 26656686
Viruses. 2020 Aug 29;12(9):
pubmed: 32872471
Cell. 1996 Mar 22;84(6):941-51
pubmed: 8601317
Neuron. 2007 Mar 1;53(5):639-47
pubmed: 17329205
Viruses. 2021 May 20;13(5):
pubmed: 34065574
J Gen Virol. 2018 Apr;99(4):447-448
pubmed: 29465028
Nat Rev Microbiol. 2017 Mar;15(3):161-168
pubmed: 28134265
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11366-70
pubmed: 8876141

Auteurs

Martina Oberhuber (M)

Max von Pettenkofer-Institute Virology & Gene Center, LMU Munich, 81377 Munich, Germany.

Anika Schopf (A)

Max von Pettenkofer-Institute Virology & Gene Center, LMU Munich, 81377 Munich, Germany.

Alexandru Adrian Hennrich (AA)

Max von Pettenkofer-Institute Virology & Gene Center, LMU Munich, 81377 Munich, Germany.

Rosalía Santos-Mandujano (R)

Max von Pettenkofer-Institute Virology & Gene Center, LMU Munich, 81377 Munich, Germany.

Anna Gesine Huhn (AG)

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, 69120 Heidelberg, Germany.

Stefan Seitz (S)

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, 69120 Heidelberg, Germany.

Christiane Riedel (C)

Institute of Virology, University of Veterinary Medicine Vienna, Vienna 1210, Austria.

Karl-Klaus Conzelmann (KK)

Max von Pettenkofer-Institute Virology & Gene Center, LMU Munich, 81377 Munich, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH